NEW YORK – Eurobio Scientific said on Tuesday that it has received CE marking for its EBX 042 FluCoSyn test, which can identify viruses for the main flu-like symptoms.
The Paris-based firm said the RT-PCR assay can be used to test for SARS-CoV-2, influenza A and B, and respiratory syncytial virus from one patient sample. More specifically, the multiplex kit has five targets, the R and N genes for SARS-CoV-2; one common target for influenza A and B; one target for RSV; and one target for the control integrated into each test to validate the correct functioning of the reaction.
Eurobio said the test can be used directly on any open instrument, including portable systems, and it allows for detection of pathogens in about 75 minutes.